Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review

    December 2020 in “ Dermatologic Therapy ”
    Nafise Yazdanian, Samaneh Mozafarpoor, Azadeh Goodarzi
    Studysummary This review found that oral and topical phosphodiesterase inhibitors and topical prostaglandin analogues are safe and effective treatments for various skin diseases, including psoriasis, atopic dermatitis, vitiligo, and alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 17

    1. Therapeutic Potential of Bimatoprost for the Treatment of Eyebrow Hypotrichosis Drug Design Development and Therapy · 2018
    2. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017
    3. Bimatoprost for the Treatment of Eyelash, Eyebrow, and Scalp Alopecia Expert Opinion on Investigational Drugs · 2017
    4. 15-Deoxy Prostaglandin J2, The Nonenzymatic Metabolite Of Prostaglandin D2, Induces Apoptosis In Keratinocytes Of Human Hair Follicles: A Possible Explanation For Prostaglandin D2-Mediated Inhibition Of Hair Growth Naunyn-Schmiedeberg's Archives of Pharmacology · 2016
    5. Bimatoprost Versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study Dermatology · 2015
    6. Alopecia Areata: Overview and Treatment Options Current problems in dermatology · 2015
    7. Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial British journal of dermatology/British journal of dermatology, Supplement · 2014
    8. Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss Journal of Investigative Dermatology Symposium Proceedings · 2013
    9. Treatment of Eyebrow Hypotrichosis Using Bimatoprost: A Randomized, Double-Blind, Vehicle-Controlled Pilot Study Dermatologic surgery · 2013
    10. Prostaglandin D2 Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia Science Translational Medicine · 2012
    11. A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2011
    12. Eyelash Preservation During Chemotherapy and Topical Prostaglandin Therapy Archives of internal medicine · 2010
    13. Bimatoprost in the Treatment of Eyelash Hypotrichosis Clinical ophthalmology · 2010
    14. Latanoprost in the Treatment of Eyelash Alopecia in Alopecia Areata Universalis Journal of The European Academy of Dermatology and Venereology · 2009
    15. Successful Use of Bimatoprost in the Treatment of Eyelash Alopecia Clinical and Experimental Dermatology · 2009
    16. Lash Ptosis Caused by Latanoprost American journal of ophthalmology · 2005
    17. Effect of Latanoprost on Hair Growth in the Bald Scalp of the Stump-Tailed Macaque: A Pilot Study 2002